8-KEarnings & ResultsExhibits & Filings

THERMO FISHER SCIENTIFIC INC. 8-K Report, Financial Results (Jan 30, 2019)

Filed January 30, 2019For Securities:TMO

Summary

Thermo Fisher Scientific Inc. (TMO) filed an 8-K on January 30, 2019, to report its financial results for the fiscal quarter ended December 31, 2018. While the filing itself is brief and primarily serves to attach the earnings press release, the attached document (Exhibit 99.1) contains the crucial financial details. Investors should refer to the press release for comprehensive information on the company's performance during the fourth quarter of 2018. The information furnished in this 8-K, specifically the earnings release, provides the latest quarterly financial condition and results of operations. It is important for investors to note that this information is "furnished" and not "filed" under Section 18 of the Exchange Act, meaning it has a different regulatory implication than formally filed information, though it still serves as a primary source for the company's reported results.

Key Highlights

  • 1Thermo Fisher Scientific announced its fourth-quarter and full-year 2018 financial results on January 30, 2019.
  • 2The 8-K filing serves as a notification and attachment mechanism for the official earnings press release.
  • 3Key financial metrics and operational performance details are contained within the attached press release (Exhibit 99.1).
  • 4Investors should consult the press release for specific figures on revenue, earnings per share, and segment performance.
  • 5The information is considered "furnished" under the 8-K filing, not "filed" for Section 18 purposes.
  • 6This filing provides the most recent financial update available as of January 30, 2019.

Frequently Asked Questions

The primary purpose of this 8-K filing is to formally announce and attach Thermo Fisher Scientific's earnings press release for the fiscal quarter ended December 31, 2018, and by extension, the full fiscal year 2018. It ensures that this important financial information is publicly disclosed in accordance with SEC regulations.

The actual financial results, including revenue, earnings per share, segment performance, and management's commentary, are detailed in the press release attached as Exhibit 99.1 to this 8-K filing. Investors should carefully review this press release for comprehensive information.

In the context of an 8-K, information labeled as 'furnished' (like the earnings release here) is generally considered to be provided to the SEC but does not carry the same legal liabilities under Section 18 of the Exchange Act as 'filed' information. However, it remains a key source of disclosure for investors regarding the company's financial performance.

This filing itself does not contain the specific financial numbers. Investors need to access the attached press release (Exhibit 99.1) to understand the key takeaways, such as revenue growth, profitability trends, and performance across Thermo Fisher Scientific's various business segments for Q4 and the full year 2018.